AQP4 and myeloid sarcoma: The mixed-model analysis, adjusted for sex, age and BMI, for obtaining the diagnosis MOGAD or MS in reference to AQP4-IgG+ NMOSD revealed that the OR for females to be diagnosed as MOGAD and MS was 0.31 (95% confidence interval (CI): [0.106, 0.911], p = 0.033) and 0.172 (95% CI [0.066, 0.447], p < 0.001), respectively, in comparison to being diagnosed with AQP4-IgG+ NMOSD.